Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Van Geet

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Current Medicinal Chemistry|September 23, 2010
Regulators of platelet cAMP levels: clinical and therapeutic implicationsL Noé, K Peeters, B Izzi, et al.
Kidney International|October 10, 1998
Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndromeC Van Geet, W Proesmans, J Arnout, et al.
Pediatric Research|October 17, 1998
Velocardiofacial syndrome patients with a heterozygous chromosome 22q11 deletion have giant plateletsC Van Geet, K Devriendt, B Eyskens, et al.
Lancet (London, England)|January 12, 1991
Possible platelet contribution to pathogenesis of transient neonatal hyperammonaemia syndromeC Van Geet, L Vandenbossche, E Eggermont, et al.
International Journal of Legal Medicine|November 12, 2005
delta-Storage pool disease: a pitfall in the forensic investigation of sudden anal blood loss in children: a case reportK De Munnynck, C Van Geet, R De Vos, et al.
Thrombosis and Haemostasis|August 13, 1990
Ridogrel, a combined thromboxane synthase inhibitor and receptor blocker, decreases elevated plasma beta-thromboglobulin levels in patients with documented peripheral arterial diseaseB Hoet, J Arnout, C Van Geet, et al.
Journal of Thrombosis and Haemostasis : JTH|June 26, 2009
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorderC Hermans, C Wittevrongel, C Thys, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
Increased thromboxane formation in diabetic pregnancy as a possible contributor to preeclampsiaF A Van Assche, B Spitz, M Hanssens, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 18, 1995
[Transient erythroblastopenia in 4 children]M Carrette, P Brock, A Uyttebroeck, et al.
Thrombosis and Haemostasis|October 5, 2001
Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleedingK Freson, M F Hoylaerts, J Jaeken, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Current Medicinal Chemistry|September 23, 2010
Regulators of platelet cAMP levels: clinical and therapeutic implicationsL Noé, K Peeters, B Izzi, et al.
Kidney International|October 10, 1998
Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndromeC Van Geet, W Proesmans, J Arnout, et al.
Pediatric Research|October 17, 1998
Velocardiofacial syndrome patients with a heterozygous chromosome 22q11 deletion have giant plateletsC Van Geet, K Devriendt, B Eyskens, et al.
Lancet (London, England)|January 12, 1991
Possible platelet contribution to pathogenesis of transient neonatal hyperammonaemia syndromeC Van Geet, L Vandenbossche, E Eggermont, et al.
International Journal of Legal Medicine|November 12, 2005
delta-Storage pool disease: a pitfall in the forensic investigation of sudden anal blood loss in children: a case reportK De Munnynck, C Van Geet, R De Vos, et al.
Thrombosis and Haemostasis|August 13, 1990
Ridogrel, a combined thromboxane synthase inhibitor and receptor blocker, decreases elevated plasma beta-thromboglobulin levels in patients with documented peripheral arterial diseaseB Hoet, J Arnout, C Van Geet, et al.
Journal of Thrombosis and Haemostasis : JTH|June 26, 2009
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorderC Hermans, C Wittevrongel, C Thys, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
Increased thromboxane formation in diabetic pregnancy as a possible contributor to preeclampsiaF A Van Assche, B Spitz, M Hanssens, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 18, 1995
[Transient erythroblastopenia in 4 children]M Carrette, P Brock, A Uyttebroeck, et al.
Thrombosis and Haemostasis|October 5, 2001
Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleedingK Freson, M F Hoylaerts, J Jaeken, et al.
Pageof 5